SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (266)11/20/2006 9:13:16 PM
From: tom pope  Respond to of 684
 
Recap.com maintains a database of biotechs MC vs cash on hand, or at least it did at one point in time. Drawback is that the subscription is 1k p.a., plus a $500 initiation fee. Just like a gym or a country club - admittedly an expensive gym but a cheap country club.



To: Mike McFarland who wrote (266)11/27/2006 3:01:55 PM
From: Steve Lokness  Respond to of 684
 
Mike;

Looks like you can move up INHX a notch.

TGEN, DYAX and now INHX. Not sure what to think. I sure wish I had more faith in the SEC to keep out the scum. Maybe the newest strategy is to pick up the dogs of the thinest traded biotechs and wait until the off shore accounts are attracted to them - if indeed that is what's going on?

Steve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News